Abstract:
BACKGROUND. Ongoing quantification of the disease burden attributable to smoking is important to monitor and strengthen tobacco
control policies.
OBJECTIVES. To estimate the attributable burden due to smoking in South Africa for 2000, 2006 and 2012.
METHODS. We estimated attributable burden due to smoking for selected causes of death in South African (SA) adults aged ≥35 years for 2000,
2006 and 2012. We combined smoking prevalence results from 15 national surveys (1998 - 2017) and smoking impact ratios using national
mortality rates. Relative risks between smoking and select causes of death were derived from local and international data.
RESULTS. Smoking prevalence declined from 25.0% in 1998 (40.5% in males, 10.9% in females) to 19.4% in 2012 (31.9% in males, 7.9% in
females), but plateaued after 2010. In 2012 tobacco smoking caused an estimated 31 078 deaths (23 444 in males and 7 634 in females),
accounting for 6.9% of total deaths of all ages (17.3% of deaths in adults aged ≥35 years), a 10.5% decline overall since 2000 (7% in males; 18% in
females). Age-standardised mortality rates (and disability-adjusted life years (DALYs)) similarly declined in all population groups but remained
high in the coloured population. Chronic obstructive pulmonary disease accounted for most tobacco-attributed deaths (6 373), followed by
lung cancer (4 923), ischaemic heart disease (4 216), tuberculosis (2 326) and lower respiratory infections (1 950). The distribution of major
causes of smoking-attributable deaths shows a middle- to high-income pattern in whites and Asians, and a middle- to low-income pattern in
coloureds and black Africans. The role of infectious lung disease (TB and LRIs) has been underappreciated. These diseases comprised 21.0% of
deaths among black Africans compared with only 4.3% among whites. It is concerning that smoking rates have plateaued since 2010.
CONCLUSION. The gains achieved in reducing smoking prevalence in SA have been eroded since 2010. An increase in excise taxes is the most
effective measure for reducing smoking prevalence. The advent of serious respiratory pandemics such as COVID-19 has increased the urgency
of considering the role that smoking cessation/abstinence can play in the prevention of, and post-hospital recovery from, any condition.
